FT-002

N/A

Report date: 2024/09/24 14:16:41

Base Information

Drug NameFT-002
Drug Alias NameFT-002FT002
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV5 vector
Mechanisms of ActionRPGR gene transference
TargetsX-linked retinitis pigmentosa GTPase regulator
Therapy Area/IndicationsRetinitis PigmentosaEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesFrontera Therapeutics (Shanghai) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesFrontera Therapeutics (Shanghai) Co LtdFangtuo Biotechnology (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A